Bioponic Phytoceuticals, Inc. today announced that its Curecumin(TM) (a Bioresonant Phytotherapeutic(R) form of Turmeric containing curcumin), may be an important treatment for prostate cancer.
"Curcumin, a turmeric root extract, has been shown to possess activity in the treatment and prevention of cancer, multiple sclerosis, and Alzheimer's disease," according to a 3/7/2007 article posted on UroToday.com. "The molecular mechanism for its anticancer effect is largely unknown, although it is thought to inhibit the synthesis of MDM2, an oncoprotein known to bind p53 and modulate p21 expression. In the March 1 issue of Cancer Research, Li and colleagues from the Comprehensive Cancer Center of the University of Alabama report on a study designed to elucidate the molecular anticancer effect of curcumin in a preclinical prostate cancer model." "Curcumin was found to decrease the mRNA and protein expression of the oncoprotein MDM2 and to enhance the expression of tumor modulator p21." "This well-performed study provides an elegant mechanistic explanation for the anticancer effect of curcumin."
Read full story in Medical News Today.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment